PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancer

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer.

Lobe Sciences Announces Update | Psychedelic Invest

VANCOUVER, British Columbia, June 04, 2024–(BUSINESS WIRE)–Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a biopharmaceutical company focused on developing transformative medicines

June 11, 2024

After Bristol Myers pulls out of collaboration, Ikena Oncology lays off 35% of staff and trims cancer pipeline

Ikena Oncology is cutting 35% of its workers to help fund two oncology candidates after dumping two other cancer assets it was slated to work

January 20, 2024

BioAge and Novartis seek drug targets for ageing-related conditions

The partnership aims to discover and validate therapeutic drug targets that address ageing-related diseases. Credit: Dragana Gordic/Shutterstock. BioAge Labs has entered a multi-year research partnership

December 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.